Jason Patrick Meyenburg - Jan 3, 2022 Form 4 Insider Report for Gemini Therapeutics, Inc. /DE (IRON)

Role
Chief Executive Officer, Director
Signature
/s/ Brian Piekos, attorney-in-fact
Stock symbol
IRON
Transactions as of
Jan 3, 2022
Transactions value $
$0
Form type
4
Date filed
1/5/2022, 03:08 PM
Previous filing
May 18, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IRON Restricted Stock Units Award $0 +124K $0.00 124K Jan 3, 2022 Common Stock 124K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents the right to receive one share of Gemini Therapeutics, Inc. common stock.
F2 These Restricted Stock Units shall vest in accordance with certain performance based metrics.